课题基金 / 基金详情

Posttranslational modifications in Marfan’s disease mediated by myeloperoxidase (A04+)

Posttranslational modifications in Marfan’s disease mediated by myeloperoxidase (A04+)
髓过氧化物酶 (A04) 介导的马凡氏病翻译后修饰
批准号:
426122627
负责人:
金额:
$0.0万
依托单位国家:
德国
项目类别:
CRC/Transregios
财政年份:
2019
资助国家:
德国
项目状态:
已结题
起止时间:
2018-12-31 至 2022-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This project aims to uncover the role of the innate immune system in Marfan Syndrome (MFS) and will define the interplay between extracellular matrix proteins, matrix-degrading enzymes, and myeloperoxidase (MPO) in MFS-related aortic disease. We hypothesize that innate immune cells extravasating into the aorta contribute to disease progression by their capacity to produce MPO, which exerts potent matrix destabilizing effects and affects the structural integrity of the vessel. Once the causality has been established, we propose to pharmacologically inhibit MPO in murine models of MFS as a new therapeutic strategy against aortic disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
蛋白精氨酸甲基化转移酶PRMT5调控PPARG促进巨噬细胞M2极化及其在肿瘤中作用的机制研究
  • 批准号:
    82371738
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    郑英霞
  • 依托单位: